Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Symbol
OMIC on Nasdaq
Shares outstanding
2,534,263
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
0
Total reported value
$0
Share change
-3,651
Value change
-$512,746
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Domain Partners IX, L.P. 5% $38,888 125,446 Domain Partners IX, L.P. 31 Dec 2024

As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC). This represents 0% of the company’s total 2,534,263 outstanding shares.

Institutional Holders of Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$512,746 0
2025 Q3 3,651 $512,746 $140.44 1
2024 Q2 0 $0 -$13,052,261 0
2024 Q1 25,384,404 $13,052,261 -$391,183 $0.51 42
2023 Q4 26,200,325 $12,085,139 -$448,981 $0.46 46
2023 Q3 26,419,012 $10,067,225 -$3,270,135 $0.38 45
2023 Q2 32,845,842 $27,286,095 -$2,619,455 $0.83 60
2023 Q1 35,826,619 $43,351,291 -$2,059,046 $1.21 64
2022 Q4 37,209,083 $74,791,408 -$3,461,406 $2.01 78
2022 Q3 40,232,625 $100,586,827 +$1,173,014 $2.50 68
2022 Q2 39,020,271 $149,054,312 -$9,077,608 $3.82 74
2022 Q1 41,021,554 $258,711,957 +$11,776,758 $6.31 68
2021 Q4 38,927,034 $449,992,335 +$16,833,101 $11.56 61
2021 Q3 27,985,610 $312,445,188 -$10,321,341 $11.19 51
2021 Q2 27,563,135 $757,432,770 +$757,432,726 $27.48 51